Dendritic cell vaccination induces cross-reactive cytotoxic T lymphocytes specific for wild-type and natural variant human immunodeficiency virus type 1 epitopes in HLA-A*0201/Kbtransgenic mice

Clinical Immunology

Volumn 101, Issue 1, 2001, Pages 51-58

  Abdel Motal, Ussama M ^a   Friedline, Randall ^a   Poligone, Brian ^a   Pogue Caley, Rebecca R ^a   Frelinger, Jeffrey A ^a   Tisch, Roland ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

CTL; Dendritic cell; HIV; Vaccines

Indexed keywords

CD8 ANTIGEN; HLA A ANTIGEN; RNA DIRECTED DNA POLYMERASE;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN RECOGNITION; ARTICLE; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; FEMALE; HUMAN IMMUNODEFICIENCY VIRUS 1; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE; VACCINATION;

EID: 16644402785     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1006/clim.2001.5095     Document Type: Article

References (38)

1. Roles of alpha beta and gamma delta T cell subsets in viral immunity
2. Peptides naturally presented by MHC class I molecules
3. Escape of human immunodeficiency virus from immune control
4. +cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection
5. Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus
6. Antigenic specificity of antibody-dependent cytotoxicity directed against human immunodeficiency virus in antibody-positive sera
7. Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: A longitudinal analysis of rapid progressors and long-term asymptomatics
8. Strong cytotoxic T cells and weak neutralizing antibodies in a subset of persons with stable nonprogressing HIV type 1 infection
9. High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and viral load are associated with lack of disease in HIV-1-infected long-term nonprogressors
10. Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during infection
11. Late escape from an immunodominant cytotoxic T lymphocyte response associated with progression to AIDS
12. Virus escape from CTL recognition
13. Efficient processing of an antigenic sequence for presentation by MHC class I molecules depends on its neighbouring residues in the protein
14. Impaired CTL recognition due to genetic variations in the main immunogenic region of HIV-1 nef protein
15. Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition
16. Antagonist HIV-1 gag peptides induce structural changes in HLA-B8
17. A pilot clinical trial of HIV antigen-pulsed allogeneic and autologous dendritic cell therapy in HIV-infected patients
18. HIV-1-specific CTL responses primed in vitro by blood-derived dendritic cells and Th1-biasing cytokines
19. Normal immune function of monocyte-derived dendritic cells from HIV-infected individuals: Implications for immunotherapy
20. Immunobiology of dendritic cells
21. Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity
22. Dendritic cells as carriers for a cytotoxic T-lymphocyte epitope-based peptide vaccine in protection against a human papillomavirus type 16-induced tumor
23. Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo
24. Presentation of SIVgag to monkey T cells using dendritic cells transfected with a recombinant adenovirus
25. Analysis of the HLA-restricted influenza-specific cytotoxic T lymphocyte response in transgenic mice carrying a chimeric human-murine class I major histocompatibility complex
26. Gene regulating HLA class I antigen expression in T-B lymphoblast hybrids
27. Amino-terminal alteration of the HLA-A*0201-restricted human immunodeficiency virus pol peptide increases complex stability and in vitro immunogenicity
28. T cell activity after dendritic cell vaccination is dependent on both the type of antigen and mode of delivery
29. Immunogenicity of peptides bound to MHC class I molecules depends on the MHC-peptide complex stability
30. MHC class I/peptide stability: Implications for immunodominance, in vitro proliferation, and diversity of responding CTL
31. A protective cytotoxic T cell response to a subdominant epitope is influenced by the stability of the MHC class I/peptide complex and the overall spectrum of viral peptides generated within infected cells
32. The structural basis for the increased immunogenicity of two HIV-reverse transcriptase peptide variant/class I major histocompatibility complexes
33. Formation and kinetics of MHC class I-ovalbumin peptide complexes on immature and mature murine dendritic cells
34. +cytotoxic T cell-epitopes
35. Dendritic cells infected with a vaccinia vector carrying the human gp100 gene simultaneously present multiple specificities and elicit high-affinity T cells reactive to multiple epitopes and restricted by HLA-A2 and -A3
36. Dendritic cells transduced by multiply deleted HIV-1 vectors exhibit normal phenotypes and functions and elicit an HIV-specific cytotoxic T lymphocyte response in vitro
37. HIV gag mRNA transfection of dendritic cells (DC) delivers encoded antigen to MHC class I and II molecules, causes DC maturation, and induces a potent human in vitro primary immune response
38. +T cell responses from chronically infected individuals